Abivax (ABVX) Non-Current Deferred Tax Liability (2023 - 2026)

Abivax's Non-Current Deferred Tax Liability history runs 4 years deep, the most recent figure standing at $7.1 million for Q1 2026.

• In Q1 2026, Non-Current Deferred Tax Liability changed N/A year-over-year to $7.1 million; the TTM figure through Mar 2026 stood at $7.1 million (changed N/A YoY), while the FY2025 annual figure was $6.8 million, up 302.17% from the prior year.
• Non-Current Deferred Tax Liability was $7.1 million for Q1 2026 at Abivax, up from $6.8 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $7.1 million in Q1 2026 to a low of $477717.3 in Q4 2023.
• Historically, Non-Current Deferred Tax Liability has averaged $4.0 million across 4 years, with a median of $4.2 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Non-Current Deferred Tax Liability soared 254.32% in 2024, then soared 302.17% in 2025.
• A 4-year view of Non-Current Deferred Tax Liability shows it stood at $477717.3 in 2023, then soared by 254.32% to $1.7 million in 2024, then jumped by 302.17% to $6.8 million in 2025, then increased by 4.5% to $7.1 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $7.1 million (Q1 2026), $6.8 million (Q4 2025), and $1.7 million (Q4 2024), per Business Quant data.